Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Lv, Zhongjing ^a,b   Wu, Xiangbing ^a,b   Cao, Wei ^a,b   Shen, Zongze ^a,b   Wang, Lizhen ^a,b   Xie, Furong ^a,b   Zhang, Jianjun ^a,b   Ji, Tong ^a,b   Yan, Ming ^a,b   Chen, Wantao ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Research Institute of Stomatology   (China)

Author keywords

Biomarker; Cell cycle; OSCC; PTHLH; PTHrP

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; MESSENGER RNA; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN P16; SMALL INTERFERING RNA; VIRUS DNA; CELL CYCLE PROTEIN; PTHLH PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE REGULATION; CELL PROLIFERATION; COLONY FORMATION; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; OROPHARYNX CARCINOMA; OROPHARYNX SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING; CELL CYCLE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEAD AND NECK TUMOR; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH TUMOR; OROPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RNA INTERFERENCE; TIME; TUMOR CELL LINE;

BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PARATHYROID HORMONE-RELATED PROTEIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA INTERFERENCE; RNA, MESSENGER; TIME FACTORS; TRANSFECTION;

EID: 84927513934     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-014-0100-y     Document Type: Article

References (56)

1. Gaykalova DA, Mambo E, Choudhary A, Houghton J, Buddavarapu K, Sanford T, Darden W, Adai A, Hadd A, Latham G, Danilova LV, Bishop J, Li RJ, Westra WH, Hennessey P, Koch WM, Ochs MF, Califano JA, Sun W: Novel insight into mutational landscape of head and neck squamous cell carcinoma. PLoS One 2014, 9:e93102.
2. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K: The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333:1157-1160.
3. Parkin D, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
4. Pries R, Hogrefe L, Xie L, Frenzel H, Brocks C, Ditz C, Wollenberg B: Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer. Int J Mol Med 2008, 21:209-215.
5. Yan B, Li H, Yang X, Shao J, Jang M, Guan D, Zuo S, Van Waes C, Chen Z, Zhan M: Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma. PLoS One 2013, 8:e73656.
6. Cao W, Zhang ZY, Xu Q, Sun Q, Yan M, Zhang J, Zhang P, Han ZG, Chen WT: Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma. Mol Cancer 2010, 9:296.
7. Wu X, Cao W, Wang X, Zhang J, Lv Z, Qin X, Wu Y, Chen W: TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer. Mol Cancer 2013, 12:151.
8. Fan HX, Li HX, Chen D, Gao ZX, Zheng JH: Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications. J Exp Clin Cancer Res 2012, 31:90.
9. Uno K, Kato K, Shimosegawa T: Novel role of toll-like receptors in Helicobacter pylori-induced gastric malignancy. World J Gastroenterol 2014, 20:5244-5251.
10. Jo HJ, Kim YH, Shin DH, Kim MJ, Lee SJ, Jeon DO, Im SG, Jang SK, Choi JY: Hyponatremia after thyroid hormone withdrawal in a patient with papillary thyroid carcinoma. Endocrinol Metab (Seoul) 2014, 29:77-92.
11. Kuriakose MA, Chen WT, He ZM, Sikora AG, Zhang P, Zhang ZY, Qiu WL, Hsu DF, McMunn-Coffran C, Brown SM, Elango EM, Delacure MD, Chen FA: Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci 2004, 61:1372-1383.
12. Park SI, McCauley LK: Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells. Endocr Relat Cancer 2012, 19:243-254.
13. Ono N, Nakashima K, Schipani E, Hayata T, Ezura Y, Soma K, Kronenberg HM, Noda M: Constitutively active PTH/PTHrP receptor specifically expressed in osteoblasts enhances bone formation induced by bone marrow ablation. J Cell Physiol 2012, 227:408-15.
14. Casey ML, Erk A, MacDonald PC: Parathyroid hormone and parathyroid hormone-related protein stimulate adenylate cyclase in human endometrial stromal cells. Ann N Y Acad Sci 1994, 734:365-371.
15. Hoshi S, Morimoto T, Saito H, Ichizuka K, Matetsuoka R, Yanaihara A, Suzuki M, Yanaihara T, Okai T: PTHrP and PTH/PTHrP receptor expressions in human endometrium. Endocr J 2001, 48:219-225.
16. Chadwick DR, Harrison BJ, Chan P, Chong L, Peachell P: Vasoactive and proliferative effects of parathyroid hormone and parathyroid hormone-related peptide on human vascular smooth muscle. Br J Surg 2000, 87:1529-1533.
17. Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, Vasavada RC, Weir EC, Broadus AE, Stewart AF: Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 1996, 76:127-173.
18. Nakajima K, Tamai M, Okaniwa S, Nakamura Y, Kobayashi M, Niwa T, Horigome N, Ito N, Suzuki S, Nishio S, Komatsu M: Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature. Endocr J 2013, 60:557-562.
19. Sloan EK, Anderson RL: Genes involved in breast cancer metastasis to bone. Cell Mol Life Sci 2002, 59:1491-1502.
20. Hiraki A, Ueoka H, Bessho A, Segawa Y, Takigawa N, Kiura K, Eguchi K, Yoneda T, Tanimoto M, Harada M: Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia. Cancer 2002, 95:1706-1713.
21. Martín-Ventura JL, Ortego M, Esbrit P, Hernández-Presa MA, Ortega L, Egido J: Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis. Stroke 2003, 34:1783-1789.
22. Daroszewska A, Bucknall RC, Chu P, Fraser WD: Severe hypercalcaemia in B-cell lymphoma: combined effects of PTH-rP, IL-6 and TNF. Postgrad Med J 1999, 75:672-674.
23. Yan M, Yang X, Wang L, Clark D, Zuo H, Ye D, Chen W, Zhang P: Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinom. Mol Cell Proteomics 2013, 12:3271-3284.
24. Cao W, Younis RH, Li J, Chen H, Xia R, Mao L, Chen WT, Ren H: EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia. Cancer Prev Res (Phila) 2011, 4:1816-1824.
25. Sun Q, Zhang J, Cao W, Wang X, Xu Q, Yan M, Wu X, Chen W: Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. Int J Biochem Cell Biol 2013, 45:513-520.
26. Feng ZE, Xu Q, Chen WT: Epigenetic and genetic alterations-based molecular classification of head and neck cancer. Expert Rev Mol Diagn 2012, 12:279-290.
27. Xu Q, Liu X, Chen W, Zhang Z: Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference. J Transl Med 2010, 8:136.
28. Wang X, Chen WT: Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation: Angiogenesis and metastasis. Anticancer Agents Med Chem 2012, 12:994-1000.
29. Cui Z, Cao W, Li J, Song X, Mao L, Chen W: TRIM24 overexpression is common in locally advanced head and neck squamous cell carcinoma and correlates with aggressive malignant phenotypes. PLoS One 2013, 8:e63887.
30. Mizumachi T, Kano S, Sakashita T, Hatakeyama H, Suzuki S, Homma A, Oridate N, Fukuda S: Improved survival of Japanese patients with human papillomavirus-positive positive oropharyngeal squamous cell carcinoma. Int J Clin Oncol 2013, 18:824-828.
31. Stein AP, Saha S, Yu M, Kimple RJ, Lambert PF: Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time. Chem Res Toxicol 2014, 27:462-469.
32. Pausova Z, Morgan K, Fujiwara TM, Bourdon J, Goltzman D, Hendy GN: Molecular characterization of an intragenic minisatellite (VNTR) polymorphism in the human parathyroid hormone-related peptide gene in chromosome region 12p12.1-p11.2. Genomics 1993, 17:243-244.
33. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Brown EM: Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 2001, 281:E1267-E1274.
34. Mamillapalli R, Wysolmerski J: The calcium-sensing receptor couples to Galpha(s) and regulates PTHrP and ACTH secretion in pituitary cells. J Endocrinol 2010, 204:287-297.
35. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall RE, Kemp BE, Suva LJ, Rodda CP, Ebelling PR, Hudson PJ, Zajac JD: Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A 1987, 84:5048-5052.
36. Massfelder T, Helwig JJ: The parathyroid hormone-related protein system: more data but more unsolved questions. Curr Opin Nephrol Hypertens 2003, 12:35-42.
37. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, Johnson N, Orr N, dos Santos SI, Waisfisz Q, Meijers-Heijboer H, Uitterlinden AG, Rivadeneira F, Hall P, Czene K, Irwanto A, Liu J, Nevanlinna H, Aittomäki K, Biomqvist C, Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON), et al: Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012, 44:312-318.
38. Lindemann RK, Ballschmieter P, Nordheim A, Dittmer J: Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism. J Biol Chem 2001, 276:46661-46670.
39. Lindemann RK, Braig M, Hauser CA, Nordheim A, Dittmer J: Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells. Biochem J 2003, 372:787-797.
40. Firkin F, Schneider H, Grill V: Parathyroid hormone-related protein in hypercalcemia associated with hematological malignancy. Leuk Lymphoma 1998, 29:499-506.
41. Bryden AA, Hoyland JA, Freemont AJ, Clarke NW, George NJ: Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases. Br J Cancer 2002, 86:322-325.
42. Kornberg LJ, Villaret D, Popp M, Lui L, Mclaren R, Brown H, Cohen D, Yun J, McFadden M: Gene expression profiling in squamous cell carcinoma of the oral cavity shows abnormalities in several signaling pathways. Laryngoscope 2005, 115:690-698.
43. Yamada T, Tsuda M, Ohba Y, Kawaquchi H, Totsuka Y, Shindoh M: PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling. Biochem Biophys Res Commun 2008, 368:575-581.
44. Trivedi S, Mattos J, Gooding W, Godfrey TE, Ferris RL: Correlation of tumor marker expression with nodal disease burden in metastatic head and neck cancer. Otolaryngol Head Neck Surg 2013, 149:261-268.
45. Dougherty KM, Blomme EA, Koh AJ, Henderson JE, Pienta KJ, Rosol TJ, McCauley LK: Parathyroid hormone-related protein as a growth regulator of prostate carcinoma. Cancer Res 1999, 59:6015-6022.
46. Iddon J, Bundred NJ, Hoyland J, Downey SE, Baird P, Salter D, McMahon R, Freemont AJ: Expression of parathyroid hormone-related protein and its receptor in bone metastases from prostate cancer. J Pathol 2000, 191:170-174.
47. Deans C, Wiqmore S, Paterson-Brown S, Black J, Ross J, Fearon KC: Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma. Cancer 2005, 103:1810-1818.
48. Linforth R, Anderson N, Hoey R, Nolan T, Downey S, Brady G, Ashcroft L, Bundred N: Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival. Clin Cancer Res 2002, 8:3172-3177.
49. Henderson M, Danks J, Moseley J, Slavin J, Harris T, Mckinlay M, Hopper J, Martin T: Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases. J Natl Cancer Inst 2001, 93:234-237.
50. Huang H, Zhang B, Chen W, Zhou SM, Zhang YX, Gao L, Xu ZG, Qiqo YL, Tang PZ: Human papillomavirus infection and prognostic predictors in patients with oropharyngeal squamous cell carcinoma. Asian Pac J Cancer Prev 2012, 13:891-896.
51. Kawakami H, Okamoto I, Terao K, Sakai K, Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K, Nishio K, Nishimura Y, Doi K, Nakagawa K: Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer Med 2013, 2:933-941.
52. Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M: Presence of HPV in head and neck tumors: high prevalence in tonsillar localization. J Exp Clin Cancer Res 2004, 23:561-566.
53. Cai C, Chernock RD, Pittman ME, EI-Mofty SK, Thorstad WL, Lewis JS Jr: Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival. Am J Surg Pathol 2014, 38:809-815.
54. Saito Y, Ebihara Y, Ushiku T, Omura G, Kobayashi K, Ando M, Sakamoto T, Fukayama M, Yamasoba T, Asakage T: Negative human papillomavirus status and excessive alcohol consumption are significant risk factors for second primary malignancies in Japanese patients with oropharyngeal carcinoma. Jpn J Clin Oncol 2014, 44:564-569.
55. Xu Y, Liu S, Yi H, Wang J, Luo Y, Yin S: Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in Chinese patients. J Med Virol 2014, doi:10.1002/jmv.24052.
56. Li W, Thompson CH, Xin D, Cossart YE, O'Brien CJ, McNeil EB, Gao K, Scolyer RA, Rose BR: Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol 2003, 163:2185-2189.